News & Updates
Filter by Specialty:
Smoking reduces effect of methotrexate-based treatment in RA patients
Current smoking reduces the response of patients with early rheumatoid arthritis (RA) to methotrexate (MTX) in a dose-responsive manner, regardless of concomitant prednisone use, a recent study has found.
Smoking reduces effect of methotrexate-based treatment in RA patients
14 Oct 2021
Lenzilumab reduces likelihood of survival without ventilation in COVID-19 patients
In hospitalized COVID-19 patients, treatment with the novel GM-CSF* neutralizing monoclonal antibody lenzilumab led to a significant improvement in survival without invasive mechanical ventilation (SWOV), findings from the phase III LIVE-AIR study suggest.
Lenzilumab reduces likelihood of survival without ventilation in COVID-19 patients
14 Oct 2021
Wearable EMG detects poststroke muscle contractions in inactive patients
Wearable surface electromyograpghy (EMG) sensors can detect arm muscle activity in stroke survivors during standard acute care even if no such activity was observed during traditional clinical examination, according to a recent study.
Wearable EMG detects poststroke muscle contractions in inactive patients
14 Oct 2021
Climbing stairs boosts vascular function in patient with hypertension
Climbing stairs is a simple method of assessing physical activity in patients with hypertension and may lead to improved vascular function, a recent study has found.
Climbing stairs boosts vascular function in patient with hypertension
14 Oct 2021
Fatty pancreas carries increased risk of diabetes mellitus
Individuals with fatty pancreas appear to be at heightened risk of developing subsequent diabetes mellitus, but not hypertension or dyslipidaemia, as suggested in a study.
Fatty pancreas carries increased risk of diabetes mellitus
14 Oct 2021
KEYNOTE unlocks immunotherapy OS benefit in metastatic TNBC, effective in early disease
Triple-negative breast cancer (TNBC) is considered one of the highest-risk subtypes of breast cancer and has a dismal prognosis. However, immunotherapy survival benefits reported in KEYNOTE-522 and KEYNOTE-355 trials bring new hope for this indication. [Ann Oncol 2021;32:994-1004]
KEYNOTE unlocks immunotherapy OS benefit in metastatic TNBC, effective in early disease
14 Oct 2021
Common, cheap osteoporosis drug promising for T2D
The osteoporosis drug alendronate halves the risk of developing type 2 diabetes (T2D) in a nationwide, retrospective, case-control study of nearly 700,000 patients from Denmark.
